The value of lactate dehydrogenase serum levels as a prognostic and predictive factor for advanced pancreatic cancer patients receiving sorafenib

Although lactate dehydrogenase (LDH) serum levels, indirect markers of angiogenesis, are associated with a worse outcome in several tumours, their prognostic value is not defined in pancreatic cancer. Moreover, high levels are associated even with a lack of efficacy of tyrosine kinase inhibitors, co...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncotarget
Päätekijät: Faloppi, Luca, Bianconi, Maristella, Giampieri, Riccardo, Sobrero, Alberto, Labianca, Roberto, Ferrari, Daris, Barni, Sandro, Aitini, Enrico, Zaniboni, Alberto, Boni, Corrado, Caprioni, Francesco, Mosconi, Stefania, Fanello, Silvia, Berardi, Rossana, Bittoni, Alessandro, Andrikou, Kalliopi, Cinquini, Michela, Torri, Valter, Scartozzi, Mario, Cascinu, Stefano
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2015
Aiheet:
Clinical Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4741511/
https://ncbi.nlm.nih.gov/pubmed/26397228
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia